Omeros (OMER) Inventory (2014 - 2026)
Omeros (OMER) posted Inventory of $183000.0 for Q1 2026, down 74.3% sequentially from $712000.0 in Q3 2021.
Omeros (OMER) Inventory (2014 - 2026) Analysis & Trends
Omeros has reported Inventory for 9 years, with the latest figure at $183000.0 in Q1 2026.
- Quarterly Inventory changed N/A year-over-year to $183000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183000.0 (changed N/A YoY) and the FY2020 annual result came in at $1.4 million, up 18.13% from the prior year.
- Inventory fell to $183000.0 in Q1 2026 per OMER's latest filing, from $712000.0 in the prior quarter.
- Over five years, Inventory peaked at $183000.0 in Q1 2026 and troughed at $183000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 842,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 842,000.00 |
| Mar 31, 2026 | 183,000.00 |
| Sep 30, 2021 | 712,000.00 |
| Jun 30, 2021 | 978,000.00 |
| Mar 31, 2021 | 1.19 Mn |
| Dec 31, 2020 | 1.36 Mn |
| Sep 30, 2020 | 1.54 Mn |
| Jun 30, 2020 | 1.89 Mn |
| Mar 31, 2020 | 1.21 Mn |
| Dec 31, 2019 | 1.15 Mn |
| Sep 30, 2019 | 1.17 Mn |
| Jun 30, 2019 | 1.19 Mn |
| Mar 31, 2019 | 736,000.00 |
| Dec 31, 2018 | 88,000.00 |
| Sep 30, 2018 | 214,000.00 |
| Jun 30, 2018 | 235,000.00 |
| Mar 31, 2018 | 247,000.00 |
| Dec 31, 2017 | 443,000.00 |
| Sep 30, 2017 | 822,000.00 |
| Jun 30, 2017 | 905,000.00 |